Status:
RECRUITING
Therapeutic Effects of Jing Si Herbal Tea for COPD
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Conditions:
Airway Disease
Eligibility:
All Genders
20+ years
Phase:
EARLY_PHASE1
Brief Summary
Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung ti...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is a common lung disease that impairs airflow and causes breathing difficulties. COPD is a major contributor to chronic health issues and mortality globall...
Eligibility Criteria
Inclusion
- COPD patients willing to enter this study
Exclusion
- not COPD patients, no willing to enter this study
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06584786
Start Date
January 1 2022
End Date
December 31 2024
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Tzu Chi Hospital
New Taipei City, Xindan, Taiwan, 23142